ENTERAL NUTRITIONAL PRODUCT

摘要

A liquid enteral nutritional product has been formulated which has utility, for example, for persons with cancer who are not currently undergoing radiation therapy and/or chemotherapy. The nutritional product is characterized by a fatty acid profile wherein, by weight: (a) the ratio of the sum of the n-3 to n-6 fatty acids is in the range of 1.37 to 1.70; (b) Eicosapentaenoic Acid (23:6n-3) is about 2.7-3.0 % of total fatty acids; and (c) Docosahexaenoic Acid (22:6n-3) is about 1.3-1.4 % of total fatty acids. Preferably the nutritional product also contains intact protein, beta -carotene, carnitine and taurine.